Prevalência e aspectos clínicos da infecçäo congênita por citomegalovirus

Yamamoto, Aparecida Y; Figueiredo, Luiz T. M; Mussi-Pinhata, Marisa M.
J. pediatr. (Rio J.) ; 75(1): 23-8, jan.-fev. 1999. ilus, tab
Artigo em Português | LILACS | ID: lil-234271

Documentos relacionados

  1. Natural Killer Cells: From Innate to Adaptive Features.
  2. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.
  3. Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
  4. Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs.
  5. Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients.
  6. [The effect of donor cytomegalovirus serological status on the outcome of allogeneic stem cell transplantation].
  7. Centre-based comparison of double versus single prevention strategy on transfusion-transmitted cytomegalovirus in at-risk haemopoietic stem cell transplant patients and a state survey on cytomegalovirus-seronegative ordering practises.
  8. Clinical Features, Treatment Courses, and Distribution of Cytomegalovirus Genotypes among Thrombocytopenia Patients Aged Younger than 12 Months.
  9. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory.
  10. Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study.